Latest news with #BGF
Business News Wales
5 days ago
- Business
- Business News Wales
Wales Set for £100m Business Investment as Part of BGF UK-Wide £3b Pledge
BGF, the UK's most active growth capital investor, has pledged £100 million to Welsh businesses as part of its £3 billion commitment to back high-potential companies across the UK over the next five years. This commitment builds on BGF's previous investment of £47 million in Wales since 2011. The firm's regional-first strategy is designed to help scale businesses in every part of the UK. As part of the £3 billion pledge, BGF has committed £300 million to female-powered businesses across the UK, one of the largest initiatives of its kind. This follows an initial £25 million pledge to the Invest in Women Taskforce (IWT), which contributed to raising over £250 million in 2023. Since 2011, BGF portfolio companies across the UK have generated £7.1 billion in revenue growth, £1 billion in export growth, and created more than 27,000 jobs. With 74% of BGF's capital deployed outside London and the South East, BGF's mission is centred on inclusive and regional economic growth and backing entrepreneurs. Hannah King, BGF investor, BGF, said: 'We're proud of our track record in Wales and excited to increase our investment through this £100 million commitment. Welsh businesses have enormous potential, and we're here to provide the capital and support to help them grow and scale sustainably.' This commitment is part of BGF's broader strategy to increase investment from the £2.3 billion deployed between 2020 and 2024, accelerating business scaleup across the UK.
South Wales Argus
6 days ago
- Business
- South Wales Argus
BGF pledges £100 million investment in Welsh businesses
BGF's commitment is part of its £3 billion plan to support high-potential companies across the UK over the next five years. This new pledge builds on BGF's previous investment of £47 million in Wales since 2011. The firm aims to scale businesses in every part of the UK with its regional-first strategy. As part of the £3 billion pledge, BGF has committed £300 million to female-powered businesses across the UK. This is one of the largest initiatives of its kind. Since 2011, BGF portfolio companies across the UK have generated £7.1 billion in revenue growth, £1 billion in export growth, and created more than 27,000 jobs. Hannah King, BGF investor, said: "We're proud of our track record in Wales and excited to increase our investment through this £100 million commitment. "Welsh businesses have enormous potential, and we're here to provide the capital and support to help them grow and scale sustainably." This commitment is part of BGF's broader strategy to increase investment from the £2.3 billion deployed between 2020 and 2024, accelerating business scaleup across the UK. BGF provides patient minority capital and strategic support to early-stage and growth-stage companies. Its regional teams, including in Cardiff, work closely with founders to deliver tailored support.
Belfast Telegraph
6 days ago
- Business
- Belfast Telegraph
Investor pledges £100m to NI businesses over next five years
Growth capital investor BGF has pledged £100m to Northern Ireland businesses as part of its wider £3bn plan to support companies UK-wide. BGF said it had already invested £86m in NI since 2011, which it said reflected a commitment to back business with flexible capital. As part of its broader national strategy, BGF has also committed £300m to female-powered businesses across the UK. Since 2011, BGF portfolio companies across the UK have delivered £7.1bn in revenue growth, £1bn in export growth, and created more than 27,000 jobs. BGF says it has a 'regional-first' model, with 74% of capital deployed outside London and the South East. Paddy Graham, regional partner for BGF in Scotland and Northern Ireland, said: "Despite economic headwinds, Northern Ireland's entrepreneurial spirit remains strong. "With our £100m commitment, we're deepening our long-standing presence here and reaffirming our mission to support more high-potential businesses with capital and strategic guidance." This latest commitment increases BGF's national investment from the £2.3bn deployed between 2020 and 2024. NI firms supported by BGF include Connected Health in Belfast, which in January announced it had been given support with plans to hire an additional 1,000 carers over the next two years. Woodland Kitchens, a Northern Irish manufacturer and supplier of kitchen, bedroom and bathroom furniture, also announced in April last year that it had received BGF support to fund acquisitions and support future growth.
Fashion United
27-05-2025
- Business
- Fashion United
BGF commits three billion pounds in investments for UK businesses
Barclays-founded BGF has outlined a three billion pound commitment to invest in high-potential UK businesses as it looks to scale support for growth in early-stage firms. Over the next five years, the firm, which has previously invested in fashion brands like Seasalt and Strathberry, wishes to back British businesses to help drive their success, the company's chief executive officer, Andy Gregory, said in a release. He continued: 'BGF is an investment platform built to solve a hard problem. With our platform advantage, we've proven we can deploy scaleup capital into a broad base of UK businesses, in a way that is commercially rigorous, regionally inclusive, and can help businesses grow in all conditions. 'Few investors have the nationwide reach to deploy capital at the scale required to make a meaningful difference to the UK's scaleup landscape, and this next phase is about leveraging our platform advantage to unlock even greater impact for UK plc.' As part of the pledge, BGF is dedicating 300 million pounds of the fund to supporting female-powered businesses, an extension of its prior 25 million pound commitment to the Invest in Women Taskforce initiative. In her own statement, Debbie Wosskow, co-chair of the Invest in Women Taskforce, said the investment is 'one of the largest ever made in the UK'. She added: 'It marks a turning point in how we back women-led enterprise and is exactly the kind of action that can start to reshape our business landscape for the better.'
Yahoo
27-05-2025
- Business
- Yahoo
Oxford Brain Diagnostics initiates dementia diagnostic commercialisation
Oxford Brain Diagnostics (OBD) is gearing up to launch a software tool designed to evaluate the early signs of dementia by analysing MRI scans. The UK company's cloud-based Cortical Disarray Measurement (CDM) Insights software processes MRI scan data to monitor patient brain changes across multiple stages of life, outputting the data as percentiles of a normative population distribution to provide an "objective, quantifiable measure of neurodegeneration". According to OBD, CDM's assessment of microstructural and macrostructural measurements, as well as cortical thickness, will bring methods of analysis to assist clinicians in the early detection of neurodegeneration currently unavailable on the US market. CDM Insights received a breakthrough device designation from the US Food and Drug Administration (FDA) in 2020 and 510(k) clearance from the agency in January 2025. Intended for use by healthcare practitioners, including neurologists and radiologists, OBD states that the CDM software will be made available to all US healthcare facilities. OBD CEO and co-founder Dr Steven Chance commented: 'Our technology empowers clinicians with the tools they need to detect subtle brain changes and to diagnose with confidence at an early stage. 'These insights also help patients gain a better understanding of the changes happening in their brains, addressing the uncertainty often experienced with the early signs of Alzheimer's disease.' Spun out from the University of Oxford in 2018, OBD stated that it had reached this stage in its development due to a 2023 funding round led by the London-headquartered Business Growth Fund (BGF). This included additional support from existing investors, including the Oxford Technology & Innovations Fund (OTIF). Dr Chance continued: 'The support from BGF and other investors and partners is enabling us to accelerate the path to the commercialisation of our software tool and bring hope to those millions who are seeking a non-invasive, precision diagnostic tool to reveal the truth about their brain health.' The ability to detect neurodegenerative conditions earlier is an area of rising importance in pharmacology. A recent open-label extension (OLE) study (NCT06424236) of Roche's discontinued Alzheimer's drug, gantenerumab, showed signs that it could prevent the onset of the disease. Data from the OLE published in The Lancet demonstrated that the anti-amyloid drug cut the risk of developing symptoms by 50% for a subgroup of 22 participants who had no cognitive problems at the beginning of the study and who received the drug for an average of eight years. BGF investor Maggie Lau commented: 'The landscape for neurological diagnostics is evolving rapidly, particularly with the arrival of new anti-amyloid Alzheimer's drugs, sharpening the focus on early, accurate diagnosis. 'OBD's technology directly addresses this by enabling timely detection and precise monitoring of neurodegenerative disease.' "Oxford Brain Diagnostics initiates dementia diagnostic commercialisation" was originally created and published by Medical Device Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
